Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C32H31N3O4 |
| Molecular Weight | 521.6062 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(ON1C(=O)CCC1=O)C2(CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=CC=CC=C5
InChI
InChIKey=FTOLAXZXUUHQQX-UHFFFAOYSA-N
InChI=1S/C32H31N3O4/c33-24-32(26-12-6-2-7-13-26,27-14-8-3-9-15-27)20-23-34-21-18-31(19-22-34,25-10-4-1-5-11-25)30(38)39-35-28(36)16-17-29(35)37/h1-15H,16-23H2
| Molecular Formula | C32H31N3O4 |
| Molecular Weight | 521.6062 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Difenoximide is a water insoluble derivative of diphenoxylate, a chemical congener of meperidine. Difenoximide has been shown to have a greater ability than methadone to suppress opiate withdrawal in addicted mice and it has produced less physical dependence than morphine and methadone in laboratory animals. Since diphenoxylic acid is the major metabolite of both difenoximide and diphenoxylate, it is assumed that difenoximide will have essentially the same dependence liability and long-term toxicologic effects as those of diphenoxylate. Difenoximide has been given to human volunteers and it showed antidiarrheal action without side effects. Difenoximide appeared to be a potentially useful agent for ambulatory narcotic detoxification. The only significant side-effect was constipation.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/612187
2.0 and 0.5 mg gelatin capsules 4 times a day over the maximum 5 days.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:05 GMT 2025
by
admin
on
Mon Mar 31 17:58:05 GMT 2025
|
| Record UNII |
8UG1323C03
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
39481
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
3654
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110913
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
C012146
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
C73162
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
SUB07122MIG
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
8UG1323C03
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
47806-92-8
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
100000083154
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY | |||
|
DTXSID90197296
Created by
admin on Mon Mar 31 17:58:05 GMT 2025 , Edited by admin on Mon Mar 31 17:58:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |